BergerAM, KoprowskiC. Bone pain: assessment and management. BergerAM, PortenoyRK, WeissmanDE. Principles and Practice of Palliative Care and Supportive Oncology, 2nd. Philadelphia, PA: Lippincott, Williams and Wilkins, 2002.
2.
PereiraJ. Management of bone pain. PortenoyRK, BrueraE. Topics in Palliative Care, 3. New York: Oxford University Press, 1998.
3.
BrueraE, RocaE, CedaroLet al.Action of oral methyl-prednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rev, 1985; 69:751–754.
4.
TwycossR. The risks and benefits of corticosteroids in advanced cancer. Drug Safety, 1994; 11:163–178.
5.
HanksGW, TruemanT, TwycossRG. Costicosteroids in terminal cancer—a prospective analysis of current practice. Postgrad Med J, 1983; 59:702–706.
6.
KleinJF. Adverse psychiatric effects of systemic glucocorticoid therapy. Am Fam Phys, 1992; 46:1469–1474.
7.
PiperJM, RayWA, DaughertyJR, GriffinMR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med, 1991; 114:735–740.